iCANSleep
A Smartphone App to Treat Insomnia in Cancer Survivors
Do you have difficulty falling or staying asleep? Have you previously been diagnosed with cancer?
If so, we are interested in hearing from you!
About the Study
This study is open to individuals who:
- Have ever received a cancer diagnosis
- Have difficulty falling or staying asleep
- Use an iPhone
- Live in Canada
iCANSleep is an evidence-based insomnia treatment app that will be tailored to the needs and preferences of cancer survivors. We are currently looking for cancer survivors who have struggled with insomnia to test the iCANSleep app and provide feedback relating to the usability, and function of the app.
Participation in this study involves:
- A 7-week app-based CBT-I program
- 2 short surveys
- A 30-minute exit interview with a Memorial University researcher
Are you considering joining the study? Contact us below (or email icansleepapp@gmail.com) for more details or to schedule an eligibility screening!
If you have questions regarding your rights as a research participant, please contact the Health Research Ethics Authority at (709) 777-6974 or info@hrea.ca
iCANSleep App Instruction Video
Contact Us
Sleep, Health, & Wellness Lab
Department of Psychology, Memorial University, 232 Elizabeth Avenue, St. John's, Newfoundland
Phone: (403) 505-0419 OR (709) 864-8035 Email: icansleepapp@gmail.com
Study Findings
Click below to find out more about the results of this study:
Published Abstracts
IPOS 2022 - 376 | Qualitative Assessment of Needs and Preferences for a Smartphone App to Treat Insomnia in Cancer Survivors
SLEEP 2023 - 0884 User Needs and Preferences for a Smartphone App to Treat Insomnia in Cancer Survivors
SLEEP 2023 - 0868 Low-Fidelity Usability Testing of a Smartphone App to Treat Insomnia in Cancer Survivors
Our Partners
Project Funding
This research is funded by a Canadian Cancer Society Emerging Scholar Award (Survivorship) (grant #707146) and the Beatrice Hunter Cancer Research Institute, with funds provided by the Canadian Cancer Society’s JD Irving, Limited – Excellence in Cancer Research Fund.
Do you want to join our mailing list?
Those on our mailing list will be the first to receive information about new studies, interesting findings from past studies, and more!